XM_006246216 // GO:0006691 // leukotriene metabolic process // inferred from electronic annotation  /// XM_006246216 // GO:0006691 // leukotriene metabolic process // not recorded  /// XM_006246216 // GO:0010035 // response to inorganic substance // inferred from expression pattern  /// XM_006246216 // GO:0019370 // leukotriene biosynthetic process // inferred from direct assay  /// XM_006246216 // GO:0019370 // leukotriene biosynthetic process // traceable author statement  /// XM_006246216 // GO:0032496 // response to lipopolysaccharide // inferred from expression pattern  /// XM_006246216 // GO:0042493 // response to drug // inferred from expression pattern  /// XM_006246216 // GO:0043085 // positive regulation of catalytic activity // inferred from electronic annotation  /// XM_006246216 // GO:0048678 // response to axon injury // inferred from expression pattern  /// XM_006246216 // GO:0055114 // oxidation-reduction process // not recorded  /// XM_006246216 // GO:0071222 // cellular response to lipopolysaccharide // inferred from expression pattern  /// XM_006246216 // GO:0071299 // cellular response to vitamin A // inferred from expression pattern  /// XM_006246216 // GO:0019370 // leukotriene biosynthetic process // inferred from electronic annotation  /// XM_006246216 // GO:0055114 // oxidation-reduction process // --- /// XM_006246218 // GO:0006691 // leukotriene metabolic process // inferred from electronic annotation  /// XM_006246218 // GO:0006691 // leukotriene metabolic process // not recorded  /// XM_006246218 // GO:0010035 // response to inorganic substance // inferred from expression pattern  /// XM_006246218 // GO:0019370 // leukotriene biosynthetic process // inferred from direct assay  /// XM_006246218 // GO:0019370 // leukotriene biosynthetic process // traceable author statement  /// XM_006246218 // GO:0032496 // response to lipopolysaccharide // inferred from expression pattern  /// XM_006246218 // GO:0042493 // response to drug // inferred from expression pattern  /// XM_006246218 // GO:0043085 // positive regulation of catalytic activity // inferred from electronic annotation  /// XM_006246218 // GO:0048678 // response to axon injury // inferred from expression pattern  /// XM_006246218 // GO:0055114 // oxidation-reduction process // not recorded  /// XM_006246218 // GO:0071222 // cellular response to lipopolysaccharide // inferred from expression pattern  /// XM_006246218 // GO:0071299 // cellular response to vitamin A // inferred from expression pattern  /// XM_006246218 // GO:0019370 // leukotriene biosynthetic process // inferred from electronic annotation  /// XM_006246218 // GO:0055114 // oxidation-reduction process // --- /// XM_006246219 // GO:0006691 // leukotriene metabolic process // inferred from electronic annotation  /// XM_006246219 // GO:0006691 // leukotriene metabolic process // not recorded  /// XM_006246219 // GO:0010035 // response to inorganic substance // inferred from expression pattern  /// XM_006246219 // GO:0019370 // leukotriene biosynthetic process // inferred from direct assay  /// XM_006246219 // GO:0019370 // leukotriene biosynthetic process // traceable author statement  /// XM_006246219 // GO:0032496 // response to lipopolysaccharide // inferred from expression pattern  /// XM_006246219 // GO:0042493 // response to drug // inferred from expression pattern  /// XM_006246219 // GO:0043085 // positive regulation of catalytic activity // inferred from electronic annotation  /// XM_006246219 // GO:0048678 // response to axon injury // inferred from expression pattern  /// XM_006246219 // GO:0055114 // oxidation-reduction process // not recorded  /// XM_006246219 // GO:0071222 // cellular response to lipopolysaccharide // inferred from expression pattern  /// XM_006246219 // GO:0071299 // cellular response to vitamin A // inferred from expression pattern  /// XM_006246219 // GO:0019370 // leukotriene biosynthetic process // inferred from electronic annotation  /// XM_006246219 // GO:0055114 // oxidation-reduction process // --- /// ENSRNOT00000004359 // GO:0006691 // leukotriene metabolic process // inferred from electronic annotation  /// ENSRNOT00000004359 // GO:0006691 // leukotriene metabolic process // not recorded  /// ENSRNOT00000004359 // GO:0010035 // response to inorganic substance // inferred from expression pattern  /// ENSRNOT00000004359 // GO:0019370 // leukotriene biosynthetic process // inferred from direct assay  /// ENSRNOT00000004359 // GO:0019370 // leukotriene biosynthetic process // traceable author statement  /// ENSRNOT00000004359 // GO:0032496 // response to lipopolysaccharide // inferred from expression pattern  /// ENSRNOT00000004359 // GO:0042493 // response to drug // inferred from expression pattern  /// ENSRNOT00000004359 // GO:0043085 // positive regulation of catalytic activity // inferred from electronic annotation  /// ENSRNOT00000004359 // GO:0048678 // response to axon injury // inferred from expression pattern  /// ENSRNOT00000004359 // GO:0055114 // oxidation-reduction process // not recorded  /// ENSRNOT00000004359 // GO:0071222 // cellular response to lipopolysaccharide // inferred from expression pattern  /// ENSRNOT00000004359 // GO:0071299 // cellular response to vitamin A // inferred from expression pattern  /// ENSRNOT00000004359 // GO:0019370 // leukotriene biosynthetic process // inferred from electronic annotation  /// ENSRNOT00000004359 // GO:0055114 // oxidation-reduction process // --- /// NM_053639 // GO:0006691 // leukotriene metabolic process // inferred from electronic annotation  /// NM_053639 // GO:0006691 // leukotriene metabolic process // not recorded  /// NM_053639 // GO:0010035 // response to inorganic substance // inferred from expression pattern  /// NM_053639 // GO:0019370 // leukotriene biosynthetic process // inferred from direct assay  /// NM_053639 // GO:0019370 // leukotriene biosynthetic process // traceable author statement  /// NM_053639 // GO:0032496 // response to lipopolysaccharide // inferred from expression pattern  /// NM_053639 // GO:0042493 // response to drug // inferred from expression pattern  /// NM_053639 // GO:0043085 // positive regulation of catalytic activity // inferred from electronic annotation  /// NM_053639 // GO:0048678 // response to axon injury // inferred from expression pattern  /// NM_053639 // GO:0055114 // oxidation-reduction process // not recorded  /// NM_053639 // GO:0071222 // cellular response to lipopolysaccharide // inferred from expression pattern  /// NM_053639 // GO:0071299 // cellular response to vitamin A // inferred from expression pattern  /// NM_053639 // GO:0019370 // leukotriene biosynthetic process // inferred from electronic annotation  /// NM_053639 // GO:0055114 // oxidation-reduction process // --- /// AB048790 // GO:0006691 // leukotriene metabolic process // inferred from electronic annotation  /// AB048790 // GO:0006691 // leukotriene metabolic process // not recorded  /// AB048790 // GO:0010035 // response to inorganic substance // inferred from expression pattern  /// AB048790 // GO:0019370 // leukotriene biosynthetic process // inferred from direct assay  /// AB048790 // GO:0019370 // leukotriene biosynthetic process // traceable author statement  /// AB048790 // GO:0032496 // response to lipopolysaccharide // inferred from expression pattern  /// AB048790 // GO:0042493 // response to drug // inferred from expression pattern  /// AB048790 // GO:0043085 // positive regulation of catalytic activity // inferred from electronic annotation  /// AB048790 // GO:0048678 // response to axon injury // inferred from expression pattern  /// AB048790 // GO:0055114 // oxidation-reduction process // not recorded  /// AB048790 // GO:0071222 // cellular response to lipopolysaccharide // inferred from expression pattern  /// AB048790 // GO:0071299 // cellular response to vitamin A // inferred from expression pattern  /// AB048790 // GO:0019370 // leukotriene biosynthetic process // inferred from electronic annotation  /// AB048790 // GO:0055114 // oxidation-reduction process // ---